Small Molecule Videos

  1. The Art And Science Of Topical Formulations 7/3/2025

    Chief Scientific Officer Jon Lenn discusses the balance of art and science in topical formulation development, emphasizing advanced skin models for optimized delivery, activity, and product stability.

  2. A Brief Intro To CMC Compliance Through CDMO Collaborations 5/29/2025

    Chief Editor Louis Garguilo provides a brief introduction and background to our Outsourced Pharma Live Event: CMC Compliance Through CDMO Collaborations.

  3. Combination Products: Navigating Regulatory Strategy, Design Verification 5/19/2025

    Delve into the intricacies of combination products and the regulatory expectations, including risk-based determination, evaluation, and documentation approaches for performance requirements.

  4. Utilizing A Stepwise Approach For Nitrosamine Risk Mitigation 5/15/2025

    Insights and case studies demonstrate how a tailored, stepwise testing approach can effectively detect, quantify, and control nitrosamine impurities while maintaining cost efficiency.

  5. Little Patients, Big Challenges: Developing Pediatric Formulations 5/12/2025

    Explore the development of high-quality, child-friendly oral formulations, as well as learn about new testing requirements for impurities and innovative approaches to creating age-appropriate medications.

  6. The Importance Of Cognitive And Pharmacodynamic Testing During FIH Trials 5/9/2025

    Learn how to identify which cognitive and pharmacodynamic tests are required for novel CNS-active drugs and best practices on conducting them during First-In-Human (FIH) trials.

  7. AustinPx Site Tour 5/2/2025

    Take a virtual tour of AustinPx to explore advanced facilities, including KinetiSol™ technology, and discover how we enable scalable, sustainable performance.

  8. 3D Screen Printing: Breakthrough Solutions For Patient-Centric Therapies 4/29/2025

    Explore 3D screen printing’s potential to revolutionize pharmaceutical manufacturing with scalable, customizable, multi-drug tablets and precise, patient-centric drug release profiles.

  9. Bend Bioscience Capacity Update April 2025: Small Molecule 4/23/2025

    Leverage expert small molecule solutions from preclinical development to commercial manufacturing, with strengths in large-scale oral solids, advanced formulations, and more.

  10. SK pharmteco Capacity Update April 2025: Small Molecule 4/23/2025

    Join Nicholas Duda, Executive Director of Business Development, as he highlights our available capacity across North America, Europe, and Asia, and our unique capabilities.